ANNOVIS BIO (ANVS) Stock Cash Flow
USA - New York Stock Exchange - NYSE:ANVS - US03615A1088 - Common Stock
3.66 USD
+0.08 (+2.23%)
3.6009 USD
-0.06 (-1.61%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.88M | -24.59M | -56.20M | -25.33M | -14.49M | |||
| Change In Working Capital | -1.84M | 681.70K | -228.60K | -1.14M | 660.00K | |||
| Other non cash items | 1.74M | 2.01M | 16.47M | 9.15M | 4.70M | |||
| OPERATING CASH FLOW | -24.98M | -21.89M | -39.97M | -17.31M | -9.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 27.63M | 26.69M | 17.34M | 0.00 | 46.74M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 27.63M | 26.69M | 17.34M | 0.00 | 46.74M | |||
| CHANGE IN CASH | 2.65M | 4.80M | -22.62M | -17.31M | 37.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.98M | -21.89M | -39.97M | -17.31M | -9.13M | |||
| FREE CASH FLOW | -24.98M | -21.89M | -39.97M | -17.31M | -9.13M | |||
All data in USD